Evidence map›Paper›PMID 25343343›Full record

ArticleTissue engineering. Part C, Methods2015

Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds.

Anna G Maione, Yevgeny Brudno, Olivera Stojadinovic, Lara K Park, Avi Smith, Ana Tellechea, Ermelindo C Leal, Cathal J Kearney, Aristidis Veves, Marjana Tomic-Canic and 2 more

Abstract read
In one paragraph

Article in Tissue engineering. Part C, Methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Skin Organoids in Diabetic Chronic Wounds: Current Status and Future Perspectives.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Refillable silicone pump with precise switching for timed therapeutic delivery.Frontiers in bioengineering and biotechnology · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Assessing Animal Models to Study Impaired and Chronic Wounds.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Anna G Maione1 Program in Cell, Molecular, and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University , Boston, Massachusetts.
Yevgeny Brudno
Olivera Stojadinovic
Lara K Park
Avi Smith
Ana Tellechea
Ermelindo C Leal
Cathal J Kearney
Aristidis Veves
Marjana Tomic-Canic
David J Mooney
Jonathan A Garlick
Tufts University · USBeth Israel Deaconess Medical Center · USHarvard University · USUniversity of Miami · US

Funding

iPSC-derived Repair-Responsive Fibroblasts to Heal Diabetic Foot UlcersR01DK098055 · NIDDK · TUFTS UNIVERSITY BOSTON · PI GARLICK, JONATHAN A · 2012 to 2015
$2.6M
Micro-RNA Molecules as Regulators of Diabetic Wound HealingR01NR013881 · NINR · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TOMIC-CANIC, MARJANA · 2012 to 2015
$1.7M
NIDDK NIH HHS R01 DK098055NINR NIH HHS R01 NR013881
6 · The paper itself

Abstract

Diabetic foot ulcers (DFU) are a major, debilitating complication of diabetes mellitus. Unfortunately, many DFUs are refractory to existing treatments and frequently lead to amputation. The development of more effective therapies has been hampered by the lack of predictive in vitro methods to investigate the mechanisms underlying impaired healing. To address this need for realistic wound-healing models, we established patient-derived fibroblasts from DFUs and site-matched controls and used them to construct three-dimensional (3D) models of chronic wound healing. Incorporation of DFU-derived fibroblasts into these models accurately recapitulated the following key aspects of chronic ulcers: reduced stimulation of angiogenesis, increased keratinocyte proliferation, decreased re-epithelialization, and impaired extracellular matrix deposition. In addition to reflecting clinical attributes of DFUs, the wound-healing potential of DFU fibroblasts demonstrated in this suite of models correlated with in vivo wound closure in mice. Thus, the reported panel of 3D DFU models provides a more biologically relevant platform for elucidating the cell-cell and cell-matrix-related mechanisms responsible for chronic wound pathogenesis and may improve translation of in vitro findings into efficacious clinical applications.

Indexed as

AnimalsCell Culture TechniquesCytokinesDiabetic FootExtracellular MatrixFibroblastsHumansIn Vitro TechniquesKeratinocytesMaleMiceMice, Inbred C57BLNeovascularization, PathologicTissue EngineeringWound HealingCytokines

Identifiers

PMID25343343
PMCPMC4410281
OpenAlexW2327492614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.